Have a personal or library account? Click to login
Comparison of two different doses of dexmedetomidine added to lignocaine in patients posted for upper limb orthopedic surgery under intravenous regional anaesthesia Cover

Comparison of two different doses of dexmedetomidine added to lignocaine in patients posted for upper limb orthopedic surgery under intravenous regional anaesthesia

Open Access
|Dec 2022

Figures & Tables

Figure 1

Comparison between groups according to heart rate (beat/min).
Comparison between groups according to heart rate (beat/min).

Figure 2

Comparison between groups according to mean arterial blood pressure (mmHg).
Comparison between groups according to mean arterial blood pressure (mmHg).

Figure 3

Comparison between groups according to respiratory rate (b/min).
Comparison between groups according to respiratory rate (b/min).

Comparison among groups according to demographic data_

Demographic dataGroup I: Control (n=30)Group II: Dex 0.25 μg/kg (n=30)Group III: Dex 0.50 μg/kg (n=30)Testp-value
Age (years)
Range20-7021-7020-69
F = 0.9350.397
Mean ± SD41.54 ± 7.0639.04 ± 6.9240.60 ± 7.47
Sex
Male23 (76.7%)26 (86.7%)24 (80.0%)
Female7 (23.3%)4 (13.3%)6 (20.0%)x2 = 1.0150.602
ASA
I21 (70.0%)22 (73.3%)19 (63.3%)
x2 = 0.7260.696
II9 (30.0%)8 (26.7%)11 (36.7%)
Duration of surgery
(min)
Range28-6025-5927-58
F = 0.9300.399
Mean ± SD43.84 ± 7.4541.21 ± 7.3042.86 ± 7.89

Comparison between groups in terms of block and mean duration of tourniquet time_

Block (min)Group I: Control (n=30)Group II: Dex 0.25 μg/kg (n=30)Group III: Dex 0.50 μg/kg (n=30)Testp-value
Onset block of (min) sensory4.96 ± 0.903.92 ± 0.92a1.06 ± 0.35abF = 206.345<0.001**
Onset block of (min) motor12.80 ± 2.1610.69 ± 2.20a5.34 ± 1.16abF = 122.649<0.001**
Quality of block
Excellent15 (50.0%)24 (80.0%)26 (86.7%)
Good8 (26.7%)4 (13.3%)3 (10.0%)x2 = 13.2190.040*
Fair5 (16.7%)2 (6.7%)1 (3.3%)
Poor2 (6.7%)0 (0.0%)0 (0.0%)
Mean duration of tourniquet time (min)
Mean ± SD52.77 ± 4.5855.06 ± 5.2054.28 ± 4.821.7120.187

Comparison between groups according to complications_

ComplicationsGroup I: Control (n=30)Group II: Dex 0.25 μg/kg (n=30)Group III: Dex 0.50 μg/kg (n=30)x2p-value
Dry mouth1 (3.3%)2 (6.7%)3 (10.0%)
Bradycardia0 (0.0%)1 (3.3%)2 (6.7%)
Tinnitus0 (0.0%)1 (3.3%)2 (6.7%)8.2800.407
Perioral numbness0 (0.0%)1 (3.3%)2 (6.7%)
Nil29 (96.7%)25 (83.3%)21 (70.0%)

Comparison between groups according to sedation score (after tourniquet deflation), VAS score duration of analgesia, doses needed of analgesic and total dose of ketorolac_

Sedation score (after tourniquet deflation)Group I: Control (n=30)Group II: Dex 0.25 μg/ kg (n=30)Group III: Dex 0.50 μg/ kg (n=30)Testp-value
After 20 min2 (1-4)2 (1-4)2 (1-4)1.7130.207
After 40 min1 (1-3)1 (1-3)1 (1-3)1.1170.186
After 60 min1 (1-2)1 (1-2)1 (1-2)1.4400.173
VAS score
After 1 hr1 (0-3)1 (0-2)0 (0-1)1.6790.201
After 2 hrs3 (1-5)2 (1-4)a1 (0-2)ab2.3380.016*
After 3 hrs5 (1-5)3 (1-4)a1 (1-2)ab2.1890.013*
After 4 hrs4 (2-6)3 (2-5)a2 (1-4)ab2.0990.012*
After 5 hrs5 (3-7)4 (3-5)a3 (1-4)ab2.0150.006*
Duration of analgesiaF-test
Mean ± SD108.27 ± 55.00174.20 ± 67.08a331.53 ± 78.27ab86.746<0.001**
Doses needed of analgesic1.7130.207
After 40 min1 (1-3)1 (1-3)1 (1-3)1.1170.186
After 60 min1 (1-2)1 (1-2)1 (1-2)1.4400.173
VAS scorex2
1st dose30 (100.0%)30 (100.0%)30 (100.0%)0.0001.000
2nd dose30 (100.0%)26 (86.7%)17 (56.7%)19.291<0.001**
3rd dose18 (60.0%)12 (40.0%)0 (0.0%)25.200<0.001**
4th dose5 (16.7%)0 (0.0%)0 (0.0%)10.5880.005*
Total dose (Ketorolac mg/kg)F-test
Mean ± SD83.75 ± 7.5468.61 ± 6.18a47.42 ± 4.27ab264.587<0.001**
DOI: https://doi.org/10.2478/rjaic-2021-0011 | Journal eISSN: 2502-0307 | Journal ISSN: 2392-7518
Language: English
Page range: 63 - 70
Published on: Dec 29, 2022
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2022 Mostafa Saieed Mansour, Shebin El Kom, Mohamed Ahmed, Ayman Rady, Sadik Sadik, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.